Mannkind Successfully Completes Phase 1 Study of Inhaled Clofazimine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.05 -0.05 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.10 | 52 Week High | $2.51 | |||
| Open | $3.10 | 52 Week Low | $0.41 | |||
| Day High | $3.13 | P/E | N/A | |||
| Day Low | $3.04 | EPS | $-0.64 | |||
| Volume | 2,798,774 | |||||
